Atlas Trials

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Clinical trial NCT06124560 · COMPLETED

Trial details

NCT number
NCT06124560
Sponsor
Galenicum Health
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
BioequivalenceDiabetes Mellitus, Type 2
Start date
2022-10-28
Primary completion
2022-11-07
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.